News and resources | Resources
Video 7 March 2013

Fake medicines – Imminent risks to global health: remarks by Jamil Chade

By IFPMA
Share
Topics
Falsified medicinesTherapeutical products

Geneva Pharma Forum: The Threat of False Friends

Opening remarks: Jamil Chade
Fake Medicines – Imminent Risks to Global Health to Global Health

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster

Related news and resources

Statement 5 Apr 2024

Enhanced collaboration between anti-doping agency and big pharma bolsters support for clean sport among athletes

On 3 April 2024 in Athens, the International Federationof Pharmaceutical Manufacturers and Associations (IFPMA) and the World Anti-Doping Agency (WADA) signed a joint letter of intent. 

Read more
Statement 6 Jun 2023

G20 side event on “Envisaging a Global R&D Network for Research in Vaccines, Therapeutics, and Diagnostics (VTDs) to enhance Prevention, Preparedness, and Response (PPR)”

On 6 June, IFPMA delivered a statement at the G20 “Strengthening Global Collaboration on Research and Development in MCMs (Diagnostics, Vaccines, and Therapeutics” side event on “Envisaging a Global R&D Network for Research in VTDs to enhance PPR” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Position paper 12 Apr 2023

Key considerations on the scope, utility and processes around updating the WHO Essential Medicines List

The WHO Essential Medicines List (EML) is an important tool in global health and supports the achievement of the UN Sustainable Development Goals. IFPMA has published perspectives from the R&D-based industry on the utility and scope of the EML. This position paper represents IFPMA's perspective as of April 2023, ahead of the publication of the revised version of the EML.

Read more
Top